News Archive - Scott LaFee

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.

Loss of Smell Associated with Milder Clinical Course in COVID-19

Researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.

For ME/CFS Patients, Viral Immunities Come at a Devastating, Lifelong Cost

Researchers at UC San Diego School of Medicine and three German universities describe an underlying biological basis for myalgic encephalomyelitis/chronic fatigue syndrome, illustrating how efforts by the body to boost immune system protections can come at physiological cost elsewhere.

UC San Diego Health Launches Novel Coronavirus Blood Testing to Identify Past Exposure

Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.

When Damaged, the Adult Brain Repairs Itself by Going Back to the Beginning

When adult brain cells are injured, they revert to an embryonic state, say researchers at UC San Diego School of Medicine. In their newly adopted immature state, the cells become capable of re-growing new connections that, under the right conditions, can help to restore lost function.

In Wake of COVID-19 Pandemic, a Crashing Wave of Neuropsychiatric Problems?

Researchers suggest that in the aftermath of the novel coronavirus pandemic, a host of neuropsychiatric challenges may remain — or emerge — for those recovering from COVID-19 infections.

Tested and Testing: UC San Diego Health Expands COVID-19 Diagnostics

UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.

Tested and Testing: UC San Diego Health Expands COVID-19 Diagnostics

UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.

UC San Diego Health Launches Clinical Trial to Assess Antiviral Drug for COVID-19

Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.

UC San Diego Partners with 5 Leading Diagnostics Manufacturers to Boost COVID-19 Testing

Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.